PI
SNDX icon

PEAK6 Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

PEAK6 Investments’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,500
Closed -$503K – 4040
2024
Q2 		$503K Buy
+24,500
New +$513K ﹤0.01% 2237
2023
Q4 		– Sell
-5,000
Closed -$72.6K – 4801
2023
Q3 		$72.6K Buy
+5,000
New +$94.6K ﹤0.01% 3530

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Investments's SNDX Position: Q3 2024 in Review

PEAK6 Investments held its Syndax Pharmaceuticals (SNDX) position steady in Q3 2024 at 43,213 shares worth $832K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

PEAK6 Investments first reported a position in SNDX in Q2 2022 and has held it in 7 quarters since. The position peaked at $887K in Q2 2024. 210 funds tracked by Wall St. Rank hold SNDX as of Q3 2024.

  • PEAK6 Investments held 43,213 shares of Syndax Pharmaceuticals worth $832K as of Q3 2024.
  • PEAK6 Investments left its Syndax Pharmaceuticals share count unchanged in Q3 2024.
  • Syndax Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2030 holding.
  • PEAK6 Investments first reported a position in Syndax Pharmaceuticals in Q2 2022 and has held it in 7 quarters since.
  • PEAK6 Investments's Syndax Pharmaceuticals position peaked at $887K in Q2 2024.
  • 210 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.